1st line therapy
Usual PathogenHelicobacter pylori
Concomitant quadruple therapy
- Success rate 80-85%
| Empiric Therapy | Dose | Duration |
|---|---|---|
| [PPI | bid | 14 days |
| + | ||
| Amoxicillin | 1g PO bid | |
| + | ||
| Clarithromycin | 500mg PO bid | |
| + | ||
| Metronidazole] | 500mg PO bid |
or
Bismuth quadruple therapy
| Empiric Therapy | Dose | Duration |
|---|---|---|
| [PPI | bid | 14 days |
| + | ||
| Bismuth subsalicylate | 2 tabs (524mg) PO qid | |
| + | ||
| Metronidazole | 500mg PO qid | |
| + | ||
| Tetracycline] | 500mg PO qid |